These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 1833455

  • 1. Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44.
    Rothman BL, Blue ML, Kelley KA, Wunderlich D, Mierz DV, Aune TM.
    J Immunol; 1991 Oct 15; 147(8):2493-9. PubMed ID: 1833455
    [Abstract] [Full Text] [Related]

  • 2. Elevation of intracellular cAMP in human T lymphocytes by an anti-CD44 mAb.
    Rothman BL, Kennure N, Kelley KA, Katz M, Aune TM.
    J Immunol; 1993 Dec 01; 151(11):6036-42. PubMed ID: 7504012
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas.
    Guo YJ, Ma J, Wong JH, Lin SC, Chang HC, Bigby M, Sy MS.
    Cell Immunol; 1993 Nov 01; 152(1):186-99. PubMed ID: 7694807
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. HLA class II molecules on monocytes regulate T cell proliferation through physical interaction in the CD3 activation pathway.
    Ruggiero G, Racioppi L, Manzo C, Pirozzi G, D'Oro U, Ferrone S, Zappacosta S, Fontana S.
    Eur J Immunol; 1991 Jan 01; 21(1):29-33. PubMed ID: 1825060
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M, Guy R, Waldmann H, Glennie M, Alexander DR.
    Cell Immunol; 1998 May 01; 185(2):101-13. PubMed ID: 9636688
    [Abstract] [Full Text] [Related]

  • 16. Does co-aggregation of the CD45 and CD3 antigens inhibit T cell antigen receptor complex-mediated activation of phospholipase C and protein kinase C?
    Shivnan E, Biffen M, Shiroo M, Pratt E, Glennie M, Alexander D.
    Eur J Immunol; 1992 Apr 01; 22(4):1055-62. PubMed ID: 1532359
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Activation of the interleukin 2 pathway precedes CD3-T cell receptor expression in thymic development. Differential growth requirements of early and mature intrathymic subpopulations.
    Toribio ML, De la Hera A, Marcos MA, Márquez C, Martínez C.
    Eur J Immunol; 1989 Jan 01; 19(1):9-15. PubMed ID: 2522051
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R, Yssel H, de Vries JE.
    J Immunol; 1993 Jun 01; 150(11):4754-65. PubMed ID: 7684412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.